Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: MAV, FOR, CFG

/R E M I N D E R -- Media Advisory - Prime Minister's itinerary for Thursday, September 24, 2020/


OTTAWA, ON, Sept. 23, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario


Private meetings.


The Prime Minister will participate in a briefing on COVID-19 with the Chief Public Health Officer of Canada, Dr. Theresa Tam.


The Prime Minister will participate in a High-Level Roundtable on Climate Action during the United Nations General Assembly. The virtual event will be livestreamed from 11:30 a.m. to 1:00 p.m. at http://webtv.un.org/.


The Prime Minister will speak with the Prime Minister of Jamaica, Andrew Holness.


10:00 a.m.

The Prime Minister will deliver a statement in the House of Commons on the death of the Right Honourable John N. Turner.


2:00 p.m.

The Prime Minister will attend Question Period.

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 18:30
Striking Teamsters at pharmaceutical giant Cencora (formerly known as AmerisourceBergen) rallied today outside the company's Sacramento distribution center. The 124 warehouse workers are members of Teamsters Local 150 and have been on strike since...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....

at 17:58
More than 200 workers at American Medical Response (AMR) in Springfield and Greenfield have voted overwhelmingly to join Teamsters Local 404....

at 17:54
The American Association of Kidney Patients (AAKP), the largest and oldest independent kidney patient organization in the nation, is celebrating National Doctors Day by highlighting three top kidney medical experts and authors known for their...

at 17:20
Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today announced it granted an inducement award on March 28, 2024. One individual was...

at 17:15
Paladin Labs Inc., a subsidiary of Endo International plc , today announced Health Canada's approval of WAKIX® (pitolisant hydrochloride tablets) for the treatment of excessive daytime sleepiness (EDS) or cataplexy in pediatric patients aged 6 years...



News published on and distributed by: